ABN Amro Investment Solutions Reduces Holdings in Synopsys, Inc. $SNPS

Key Points

• ABN Amro Investment Solutions cut its Synopsys stake by 5.7% in the first quarter, selling 6,760 shares and leaving it with 110,956 shares valued at about $44 million.
• Synopsys reported strong fiscal Q2 results, with EPS of $3.35 topping estimates and revenue of $2.28 billion also above expectations, while quarterly revenue rose 41.9% year over year.
• Despite some insider selling and mixed sentiment, analysts remain broadly positive on SNPS, with a “Moderate Buy” consensus and an average price target of $570.06.

ABN Amro Investment Solutions decreased its position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 5.7% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 110,956 shares of the semiconductor company's stock after selling 6,760 shares during the period. ABN Amro Investment Solutions owned approximately 0.06% of Synopsys worth $43,992,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently made changes to their positions in SNPS. Sankala Group LLC purchased a new stake in Synopsys in the 4th quarter worth about $25,000. Thurston Springer Miller Herd & Titak Inc. bought a new stake in Synopsys in the fourth quarter worth about $28,000. Caitong International Asset Management Co. Ltd purchased a new position in shares of Synopsys during the fourth quarter valued at approximately $28,000. Atlas Capital Advisors Inc. bought a new position in shares of Synopsys during the fourth quarter valued at approximately $32,000. Finally, Phillip James Consulting Co. bought a new position in shares of Synopsys during the fourth quarter valued at approximately $36,000. Institutional investors own 85.47% of the company's stock.

Synopsys Price Performance

SNPS opened at $389.07 on Wednesday. Synopsys, Inc. has a 12-month low of $366.00 and a 12-month high of $651.73. The business's fifty day simple moving average is $464.07 and its 200-day simple moving average is $457.23. The company has a market capitalization of $74.50 billion, a price-to-earnings ratio of 90.06, a PEG ratio of 2.22 and a beta of 1.22. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33.

Synopsys (NASDAQ:SNPS - Get Free Report) last issued its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.15 by $0.20. The company had revenue of $2.28 billion for the quarter, compared to analysts' expectations of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The firm's quarterly revenue was up 41.9% on a year-over-year basis. During the same period in the prior year, the business earned $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, equities research analysts anticipate that Synopsys, Inc. will post 10.65 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on SNPS shares. BNP Paribas Exane raised their price target on Synopsys from $425.00 to $450.00 and gave the stock an "underperform" rating in a research note on Thursday, May 28th. Robert W. Baird set a $558.00 price objective on Synopsys in a research report on Thursday, May 28th. Benchmark started coverage on Synopsys in a research note on Wednesday, July 15th. They issued a "buy" rating and a $570.00 target price on the stock. KeyCorp reiterated an "overweight" rating on shares of Synopsys in a research report on Thursday, May 28th. Finally, Berenberg Bank set a $633.00 target price on shares of Synopsys in a research note on Wednesday, May 27th. Two research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Synopsys currently has an average rating of "Moderate Buy" and a consensus price target of $570.06.

Insider Buying and Selling

In related news, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the transaction, the chief financial officer directly owned 14,358 shares of the company's stock, valued at $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the transaction, the chief executive officer directly owned 75,020 shares in the company, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is currently owned by company insiders.

Trending Headlines about Synopsys

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Mizuho said Moonshot AI’s Kimi K3 release reinforces, rather than weakens, the case for agentic AI and could benefit EDA software leaders like Synopsys, prompting a “buy the dip” view after the recent selloff. Buy the dip in EDA stocks as Kimi K3 boosts agentic AI thesis: Mizuho
• Positive Sentiment: Another analysis argued Synopsys should benefit regardless of which companies win the AI race, since AI development across the industry still requires chip-design software and infrastructure. Synopsys Should Benefit No Matter Who Wins The AI Race. Here’s What Explains Its Poor Stock Performance.
• Neutral Sentiment: Technical-trading coverage said SNPS was testing an important price level and had shown signs of stabilization, suggesting traders may be watching for a reversal rather than reacting to a new business catalyst. Stock Of The Day: Will Synopsys Reverse?
• Neutral Sentiment: Broader market headlines also mentioned SNPS in the context of a firmer futures market, which may have helped sentiment somewhat, but did not add company-specific news. Stock Market Today: S&P 500, Dow Jones Futures Gain as Trump Says Iran is 'Very, Very Badly Damaged'— Eva Live, RTX, Synopsys in Focus

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.